“Barb is one of the most accomplished and skilled lawyers in the private equity industry,” said A.J. Weidhaas, co-chair of Goodwin’s Private Equity practice. “Her strategic focus on middle market private equity and M&A, emerging companies, and the healthcare, financial services and technology industries complements our full-service and capital-meets-innovation practice perfectly. We are thrilled to have Barb on board as we continue to add marquee talent to our market-leading global team.”
Shander advises private equity funds and their portfolio companies on structuring and negotiating complex transactions, including mergers and acquisitions, dispositions, equity ﬁnancings, joint ventures, commercial agreements, incentive equity and other compensation plans, leveraged dividends, corporate governance, and general corporate matters. She represents buyers and sellers in transactions involving privately held businesses, and subsidiaries and divisions of public companies, and has experience in roll-up, corporate carve-out, and distressed transactions. She represents numerous private equity funds, ranging from lower middle-market funds to multibillion-dollar funds.
Shander continues to serve as chief legal officer at WCG Clinical, where she previously held the title of executive vice president of corporate development. Prior to joining WCG Clinical, Shander was a partner at an international law firm for 24 years, most recently serving as the co-leader of the private equity group.
Bolstered by strong client demand, Goodwin has continued to invest in its premier Private Equity practice in the last 18 months with the arrival of more than 20 partners in New York, Washington, D.C., Frankfurt, Munich, London, and Hong Kong. Goodwin’s global private equity platform is approximately 400 lawyers.
Refinitiv’s latest league tables ranked Goodwin the number one firm for global M&A by deal count in calendar year 2021.